Aethlon Medical IncAEMD
Price$6.52

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $0TTM through 31 Mar 2026
Net Income -$7.2MTTM through 31 Mar 2026
Free Cash Flow -$7MTTM through 31 Mar 2026

Margins

Current

Returns

-146.3%ROE
-112.9%ROA

Balance Sheet Health

Debt / Equity0.00x
Current Ratio3.85x
Net Debt-$5Mnet cash position
Cash & Equivalents$5M

Quality Metrics

Earnings-Beat Rate0.0%

Dividend

No dividend

Segment Performance

SegmentRevenueYoYOutlook
Medical Devices$0
View details

Aethlon continues to focus on clinical development of its Hemopurifier device in oncology and infectious diseases.

All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.